Predictive value of remnant cholesterol combined with traditional blood lipid parameters for major adverse cardiovascular and cerebrovascular events in patients with prehypertension
Author:
Affiliation:

1.Department of Cardiovascular Medicine of the Second Affiliated Hospital of Dalian Medical University, Dalian, Liaoning 116023, China;2.Graduate School of Jinzhou Medical University, Jinzhou, Liaoning 121001, China;3.Department of Cardiovascular Medicine of General Hospital of Northern Theater Command, Shenyang, Liaoning 110016, China;4.Department of Respiratory Medicine, the NO.967 Hospital of PLA Joint Logistics Support Force, Dalian, Liaoning 116021, China)

Clc Number:

R5

  • Article
  • | |
  • Metrics
  • |
  • Reference [21]
  • | |
  • Cited by
  • | |
  • Comments
    Abstract:

    Aim To evaluate whether remnant cholesterol combined with traditional blood lipid parameters can improve the predictive efficacy for major adverse cardiovascular and cerebrovascular events (MACCE) in prehypertensive patients. Methods The clinical data of 421 prehypertensive patients who underwent coronary angiography for coronary heart disease or suspected coronary heart disease in General Hospital of Northern Theater Command from 2004 to 2014 were retrospectively analyzed, and various types of data before coronary angiography were recorded during hospitalization, including basic clinical baseline data such as age, gender, height, weight, blood lipids, and blood glucose. A total of 95 patients were included in the case group when they were readmitted due to MACCE during long-term follow-up (follow-up methods included but not limited to telephone, SMS, etc.); 200 patients with prehypertension but without MACCE in the concurrent cohort were selected as the control group. The differences in clinical baseline data between the two groups were analyzed and compared, multivariate Logistic regression analysis was performed for various lipid parameters to determine their OR, receiver operating characteristic (ROC) curves were used to analyze the predictive value of various lipid parameters and combined predictors for MACCE in prehypertensive patients, and MEDCALC software was used to compare the area under the curve of traditional lipid parameters and combined predictors. Results The levels of remnant cholesterol, low density lipoprotein cholesterol (LDLC), triglyceride (TG), total cholesterol (TC), non-high density lipoprotein cholesterol (non-HDLC), remnant cholesterol/HDLC, and LDLC/HDLC in the case group were significantly higher than those in the control group, and the number of patients with high-salt diet and diabetes in the case group were also higher than those in the control group, and the above differences were statistically significant (P<0.05). The results of multivariate Logistic regression analysis showed that remnant cholesterol, non-HDLC, TG, TC, remnant cholesterol/HDLC, and LDLC/HDLC were all independent predictors of prehypertension patients after adjusting for gender and age factors (P<0.01). ROC curve analysis showed that the AUC of remnant cholesterol combined with other lipid parameters in predicting the occurrence of MACCE in prehypertensive patients was 0.704, while the AUC of remnant cholesterol or other lipid parameters in predicting the occurrence of MACCE in prehypertensive patients was less than that of the combined predictor; comparison of the AUC of the combined predictor with the AUC of lipid parameters alone using the DELONG method revealed significant differences in other AUC except for non-HDLC (P=0.054), which showed borderline positivity (P<0.05). Conclusions In prehypertensive patients, remnant cholesterol, LDLC, non-HDLC, TG, TC remnant cholesterol/HD-C, and LDLC/HDLC are independent risk factors for MACCE in such patients. The combined predictive value constructed by remnant cholesterol combined with other lipid parameters has a better predictive value for MACCE in prehypertensive patients.

    Reference
    [1] MACH F, BAIGENT C, CATAPANO A L, et al.2019 ESC/EAS guidelines for the management of dyslipidaemias:lipid modification to reduce cardiovascular risk.Eur Heart J, 0,1(1):111-188.
    [2] CHAPMAN M J, GINSBERG H N, AMARENCO P, et al.Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease:evidence and guidance for management.Eur Heart J, 1,2(11):1345-1361.
    [3] VARBO A, BENN M, TYBJAERG-HANSEN A, et al.Elevated remnant cholesterol causes both low-grade inflammation and ischemic heart disease, whereas elevated low-density lipoprotein cholesterol causes ischemic heart disease without inflammation.Circulation, 3,8(12):1298-1309.
    [4] 游志刚, 黄琳, 姜醒华.高血压前期血浆代谢组学特征分析.中国现代医学杂志, 7,7(30):93-97.
    [5] CHEN J, KUANG J, TANG X, et al.Comparison of calculated remnant lipoprotein cholesterol levels with levels directly measured by nuclear magnetic resonance.Lipids Health Dis, 0,9(1):132.
    [6] HOOGEVEEN R C, GAUBATZ J W, SUN W, et al.Small dense low-density lipoprotein-cholesterol concentrations predict risk for coronary heart disease:the Atherosclerosis Risk In Communities (ARIC) study.Arterioscler Thromb Vasc Biol, 4,4(5):1069-1077.
    [7] DURAN E K, ADAY A W, COOK N R, et al.Triglyceride-rich lipoprotein cholesterol, small dense LDL cholesterol, and incident cardiovascular disease.J Am Coll Cardiol, 0,5(17):2122-2135.
    [8] Kaltoft M, Langsted A, Nordestgaard B G.Triglycerides and remnant cholesterol associated with risk of aortic valve stenosis:mendelian randomization in the Copenhagen general population study.Eur Heart J, 0,1(24):2288-2299.
    [9] NORDESTGAARD B G, VARBO A.Triglycerides and cardiovascular disease.Lancet, 4,4(9943):626-635.
    [10] Ahmed O, Littmann K, Gustafsson U, et al.Ezetimibe in combination with simvastatin reduces remnant cholesterol without affecting biliary lipid concentrations in gallstone patients.J Am Heart Assoc, 8,7(24):e9876.
    [11] KUGIYAMA K, DOI H, TAKAZOE K, et al.Remnant lipoprotein levels in fasting serum predict coronary events in patients with coronary artery disease.Circulation, 9,9(22):2858-2860.
    [12] EXPERT COMMITTEE ON THE DIAGNOSIS AND CLASSIFICATION OF DIABETES MELLITUS.Report of the expert committee on the diagnosis and classification of diabetes mellitus.Diabetes Care, 3,6(Suppl 1):S5-S20.
    [13] MANSIA G, DE BACKER G, DOMINICZAK A, et al.2007 ESH-ESC guidelines for the management of arterial hypertension:the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).Blood Press, 7,6(3):135-232.
    [14] BAIGENT C, BLACKWELL L, EMBERSON J, et al.Efficacy and safety of more intensive lowering of LDL cholesterol:a meta-analysis of data from 170 000 participants in 26 randomised trials.Lancet, 0,6(9753):1670-1681.
    [15] MILLS E J, WU P, CHONG G, et al.Efficacy and safety of statin treatment for cardiovascular disease:a network meta-analysis of 170 255 patients from 76 randomized trials.QJM, 1,4(2):109-124.
    [16] VARBO A, BENN M, NORDESTGAARD B G.Remnant cholesterol as a cause of ischemic heart disease:evidence, definition, measurement, atherogenicity, high risk patients, and present and future treatment.Pharmacol Ther, 4,1(3):358-367.
    [17] ANDERSON T J, GREGOIRE J, HEGELE R A, et al.2012 update of the Canadian Cardiovascular Society guidelines for the diagnosis and treatment of dyslipidemia for the prevention of cardiovascular disease in the adult.Can J Cardiol, 3,9(2):151-167.
    [18] RAY K K, KASTELEIN J J, BOEKHOLDT S M, et al.The ACC/AHA 2013 guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular disease risk in adults:the good the bad and the uncertain:a comparison with ESC/EAS guidelines for the management of dyslipidaemias 2011.Eur Heart J, 4,5(15):960-968.
    [19] JACOBSON T A, ITO M K, MAKI K C, et al.National lipid association recommendations for patient-centered management of dyslipidemia:part 1:full report.J Clin Lipidol, 5,9(2):129-169.
    [20] ASZTALOS B F, ROHEIM P S, MILANI R L, et al.Distribution of ApoAⅠ-containing HDL subpopulations in patients with coronary heart disease.Arterioscler Thromb Vasc Biol, 0,0(12):2670-2676.
    [21] RIDKER P M, RIFAI N, COOK N R, et al.Non-HDL cholesterol, apolipoproteins AⅠ and B100, standard lipid measures, lipid ratios, and CRP as risk factors for cardiovascular disease in women.JAMA, 5,4(3):326-333.
    Related
    Cited by
Get Citation

CHEN Yan, WANG Zhaofeng, XU Feng, XU Qing, ZHOU Qingzhi, Lü Zhibo, CHEN Shengyue, ZHAO Xin. Predictive value of remnant cholesterol combined with traditional blood lipid parameters for major adverse cardiovascular and cerebrovascular events in patients with prehypertension[J]. Editorial Office of Chinese Journal of Arteriosclerosis,2022,30(4):335-340.

Copy
Related Videos

Share
Article Metrics
  • Abstract:
  • PDF:
  • HTML:
  • Cited by:
History
  • Received:May 24,2021
  • Revised:June 11,2021
  • Online: March 31,2022
Article QR Code